Author

P. Hamminger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1

Frequent Co-Authors

C. Bock· 2 shared W. Ellmeier· 2 shared A. Bergthaler· 1 shared A. Hladik· 1 shared A. Tiefenbacher· 1 shared B. Agerer· 1 shared B. H. Ramsahoye· 1 shared C. Campbell· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Bock

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function

V. Stolz, R. de Freitas e Silva, R. Rica, C. Zhu, T. Preglej, P. Hamminger, D. Hainberger, M. Alteneder, L. Müller, M. Waldherr, D. Waltenberger, A. Hladik, B. Agerer, M. Schuster, T. Frey, , W. Ellmeier

This study shows NCOR1 regulates Treg cell differentiation and suppressive function by maintaining transcriptional integrity in both naive and effector states.

eLife · Oct 28, 2024Peer-reviewedImmunology

Requirement of DNMT1 to orchestrate epigenomic reprogramming during NPM-ALK driven T cell lymphomagenesis

E. Redl, R. Sheibani-Tezerji, P. Hamminger, G. Timelthaler, M. R. Hassler, S. Lagger, T. Dillinger, L. Hofbauer, M. Zrimsek, A. Tiefenbacher, M. Kothmayer, C. H. Dietz, B. H. Ramsahoye, L. Kenner, C. Bock, , G. Egger

This study shows that DNMT1 is essential for maintaining tumor-specific methylation during NPM-ALK driven T cell lymphomagenesis, despite oncogenic signaling.

bioRxiv · Apr 9, 2020 · PreprintCancer Biology